Introduction
The most common melanoma is believed to arise through the de novo proliferation of basilar epidermal melanocytes. During the course of malignant development, various molecular alternations may occur in melanocytes. Among the candidate target molecules, recent studies have highlighted the importance of the Notch pathway for melanoma progression (Nickoloff et al., 2003; Hoek et al., 2004; Balint et al., 2005) . The Notch pathway mediates tissue differentiations and homeostasis by controlling stem cells. Interestingly, recent studies indicated that melanoma contains a subpopulation of tumor stem cells that can differentiate into multiple cell lineages and contribute to tumor progression (Fang et al., 2005; Grichnik et al., 2006) . It is likely that aberrant Notch pathway participated in the tumorigenesis of melanoma by regulating tumor stem cells.
Skeletrophin is located on human chromosome 1p36.32, where putative tumor suppressor factors involved in invasive melanoma have long been postulated (Bale et al., 1989; Goldstein et al., 1993; Dracopoli et al., 1998; Poetsch et al., 2003) . In fact, a previous immunohistochemical staining revealed that invasive malignant melanoma did not express skeletrophin, whereas most benign nevi expressed skeletrophin in the cytoplasm (Takeuchi et al. 2003) . However, whether skeletrophin is a novel tumor suppressor factor or its expression is simply altered as a result of phenotypic change during melanoma progression has remained unclear.
Recent findings, including our own, clearly indicate that skeletrophin is a novel ubiquitin ligase, which targets Notch ligands and mediates ligand-dependent Notch activation (Koo et al., 2005a; Takeuchi et al., 2005) . Skeletrophin and its paralogue, mind bomb (the former is also reported as mindbomb homolog 2 (MIB2), and the latter as DIP-1 (DAPK (deathassociated protein kinase)-interacting protein) (Jin et al., 2002) or mind bomb-1) mediate ligand-dependent Notch activation by ubiquitination of the intracellular region of Notch ligands in a RING-finger domain-dependent manner. These findings indicate that the silencing of skeletrophin expression may be related to aberrant Notch signal transduction in melanoma cells.
Recent studies have also established the concept that hypermethylation in GC-rich promoter regions is a major epigenetic event that reduces the expression of many tumor suppressor factors. Notably, a demethylating agent restored skeletrophin expression in a cultured melanoma cell line in a previous study (Takeuchi et al., 2003) . Therefore, we have speculated that aberrant methylation reduced skeletrophin expression in invasive melanoma. However, the promoter region of skeletrophin has not yet been identified.
In the present study, we identified a typical CpG island in the promoter region of skeletrophin, and subsequently found hypermethylation in many invasive melanoma specimens, but not in non-invasive or benign nevi. Notably, the identified promoter region also contained an E-box-related element, with which Snail interacted. Snail is known to repress transcription of various tumor suppressor factors and is overexpressed in malignant melanoma. We subsequently examined whether Snail could repress skeletrophin promoter activity. Further, we report that exogenously expressed skeletrophin, but not a RING mutant, markedly reduced invasion activity of melanoma cells in vitro and in vivo.
We propose that abrogation of skeletrophin-mediating ubiquitin pathway may be involved in tumorigenicity of melanoma, especially melanoma invasion.
Results

Identification of skeletrophin promoter in a typical CpG island
We first identified the transcription initiation position. Primer extension method revealed that the transcription initiation position was 141 bases upstream of the start ATG codon as shown in Figure 1a . In the public database, we found GC-rich region upstream skeletrophin gene (Figure 1b ). This putative promoter sequence lacks typical TATA and CAAT boxes but contains an overlapping sequence of Sp1 and GCG motif and an activator protein-2 (AP-2)-binding element, Figure 1 Primer extension analysis (a), position of CpG nucleotides (b), nucleotide sequence analysis (c) and promoter activity (d) of the upstream region of the skeletrophin gene. (a) Primer extension analysis of skeletrophin was performed to identify the transcription start sites. Poly(A) þ RNA (lane 1) and total RNA (lane 2) from human placenta was mixed with fluorescent (Cy5)-labeled oligonucleotide, followed by reverse transcription, as described in the 'Materials and methods'. To determine the transcriptional start site, sequencing of the putative promoter region, described below, was carried out in parallel. The result shown is from one of three independent experiments and was visualized in Gel View mode. Silencing of skeletrophin in melanoma T Takeuchi et al 5 0 -GCCNNNGGC-3 0 . Notably, the sequence also contained an E-box-related 5 0 -CAAGTG-3 0 site (Figure 1c , underlined). The promoter activity of this GC-rich sequence was shown by using a secreted human placental alkaline phosphatase (SEAP) reported system (BD Biosciences Clontech). As demonstrated in Figure 1d , the candidate 496 bp nucleotides had a promoter activity. The identified promoter region of skeletrophin is matched to the standard CpG island criteria (%GC ¼ 68.3%>50%, ObsCpG/ExpCpG ¼ 0.915>0.6, length ¼ 496>200 bp).
Aberrant methylation of skeletrophin promoter in invasive melanoma specimens We subsequently designed the methylation-specific PCR (MSP). When we did not detect a wild-type band in the unmodified specimens, we did not evaluate the status of methylation. Notably, no wild-type band was found in five of 45 invasive melanoma specimens; however, we could not determine whether the absence of a wild-type band represented the lack of skeletrophin gene or was simply owing to insufficient gene status of specimens. In addition, nine of 40 specimens in which we could find neither methylation-specific nor unmethylated bands were considered as uninformative and excluded from the present study.
Six of 31 (20%) invasive melanomas but none of 25 benign nevi had aberrant methylation in the promoter region. Interestingly, all six melanomas in which a methylation-specific band was observed were in invasive phase, and none of them expressed skeletrophin. We did not find a methylation-specific band in 10 or 15 skeletrophin-negative-or -positive invasive melanoma specimens, respectively. A methylation-specific band was not observed in any of five superficial spreading melanoma specimens (melanoma restricted in the epidermis), whereas the unmethylated band was observed in all five superficial spreading melanoma. Representative results were shown in Figure 2 . These findings indicated that aberrant methylation of the promoter region, which may be related to silencing of skeletrophin expression, was present in a considerable number of invasive malignant melanomas, but not in benign nevi or superficial spreading melanoma.
Snail represses the activity of the skeletrophin promoter As described above, we found a 5 0 -CAAGTG-3 0 element in the identified skeletrophin promoter. Although typical Snail binding site consisted of a 5 0 -CAGGTG-3 0 core motif, previous studies also indicated that the zinc-finger transcriptional factor, Snail, could bind to the 5 0 -CAAGTG-3 0 element (Mauhin et al., 1993) . Therefore, DNA from tumor-rich areas of six invasive malignant melanoma specimens, numbered 1-6, were modified by bisulfite and used as templates. Note the bands of the methylated form (M) of skeletrophin gene in cases 2 and 5. In cases 4, neither methylation-specific nor unmethylation-specific bands were detected and it was counted as an uninformative case. In neither non-invasive melanoma cases, numbered 7-11, nor in benign nevi cases, numbered 12-15, was a methylation-specific band observed. Expression of skeletrophin protein in case 2 (a and b), case 10 (c and d) and case 14 (e and f) are demonstrated by hematoxylin staining (a, c and e) and immunohistochemical staining (b, d and f). Note positive signals in the cytoplasm of the tumor cells in cases 10 (d) and 14 (f), but not in case 2 (b). Immunohistochemical staining was performed with anti-skeletrophin antibody as described previously (Takeuchi et al., 2003) .
Silencing of skeletrophin in melanoma T Takeuchi et al we speculated that Snail might repress the promoter activity of skeletrophin.
As demonstrated in Figure 3a -c, Snail significantly decreased the wild-type (5 0 -CAAGTG-3 0 ), but not the mutated E-box (5 0 -AAATTT-3 0 ), skeletrophin promoter activity, designated Wt-skprom and Mut-skprom, respectively in HEK293 cells.
Subsequently, we used RNA interference to reduce Snail expression in A2058 melanoma cell line, which expressed high levels of endogenous Snail. Quantitative reverse transcription-polymerase chain reaction (RT-PCR) revealed that transfection with Snail small interfering RNA (siRNA) resulted in approximately 64-86% reduction of Snail mRNA levels compared with green fluorescent protein (GFP) siRNA control in three independent assays. Downregulation of Snail mRNA increased skeletrophin promoter activity as shown in Figure 3d . Moreover, Snail downregulation led to significant increase in the levels of skeletrophin mRNA as demonstrated in Figure 3e .
A previous study demonstrated that Snail was expressed in many melanomas but not in benign nevi (Poser et al., 2001) . Combined together with the present result, we think that aberrantly expressed Snail may participate in silencing of skeletrophin in melanoma cells.
AP-2 increased skeletrophin expression in melanoma cells
We found an AP-2-binding element, 5
0 -GCCNNN GGC-3 0 (5 0 -GCCCTGGGC-3 0 ), in the skeletrophin Figure 3 Snail suppressed the promoter activities of skeletrophin gene. SEAP reporter constructs carrying the skeletrophin promoter were transfected into HEK293 cells singly or together with the Snail expression vector. When Snail was co-expressed in HEK293 cells, the activities of the skeletrophin promoter were repressed (a). The repression of the skeletrophin promoter was dependent on the dose of Snail (a and b). The skeletrophin promoter mutant harboring 5 0 -AAATTT-3 0 instead of the E-box-related element did not show significant repressor activity by Snail expression (a and c). A2058 melanoma cells were transfected with the SEAP reporter constructs carrying the skeletrophin promoter and subsequently treated with the siRNA duplex, which targeted Snail mRNA. Downregulation of Snail mRNA (quantitative RT-PCR revealed 72% downregulation in this assay) significantly increased skeletrophin promoter activity (d). RNA interference-mediated reduction of Snail (quantitative RT-PCR revealed 86% downregulation in this assay) also increased skeletrophin mRNA levels in A2058 cells (e). The expected size of Snail, skeletrophin and G3PDH is 284, 295 and 456 bp. Representative examples of RT-PCR analysis using AP-2-expressing G361 and control cells were shown (f). AP-2-expressing cells expressed skeletrophin mRNA, whereas control cells expressed little skeletrophin mRNA. Results are taken from a single experiment representative of three yielding similar results using different transfectant clones. The expected transcript size of AP-2 is 417 bp.
Silencing of skeletrophin in melanoma T Takeuchi et al promoter. AP-2 is a well-characterized transcription factor and is believed to play a tumor-suppressor-like role in melanoma progression by regulating genes involved in invasive melanoma (see review; Tellez and Bar-Eli, 2003) . Therefore, we asked whether AP-2 expression increased skeletrophin in cultured melanoma cells. G361 melanoma cell, in which we detected little or no AP-2 expression by RT-PCR, was transfected with empty vector or AP-2-expressing vector. We obtained three independent clones, which expressed AP-2. Notably, skeletrophin was much expressed in all of three AP-2-expressing G361 clones than in control clones. The representative result was shown in Figure 3f . We think that AP-2 upregulated skeletrophin expression in melanoma cells.
Skeletrophin reduced melanoma cell invasion and soft-agar colony formation activity in a RING motif-dependent manner We subsequently established the skeletrophin-expressing cultured melanoma cells and examined their growth, invasion activities and soft-agar colony formation activity in vitro. Skeletrophin-negative melanoma cells, A2058 and Colo679 cells, were transfected with an expression vector containing full-length wild skeletrophin cDNA-or RING-mutated cDNA under the cytomegalovirus promoter.
As shown in Figure 4a , a band specific for skeletrophin was also observed in wild-type, designated A2058skwt and Colo679skwt, and mutant transfectants, designated A2058skmut and Colo679skmut, but not in original melanoma cells by Western immunoblotting. Notably, no significant differences in cell growth were found between native melanoma cells and these transfectants ( Figure 4b ).
As demonstrated in Figure 4c , A2058skwt and Colo679skwt cells, but not A2058skmut and Colo679sk-mut, exhibited a significant decrease in invasion through a Matrigel-coated filter. This result indicated that skeletrophin inhibited melanoma cells from penetrating through the basement membrane in vitro as a RINGfinger-dependent manner.
As demonstrated in Figure 4d , exogenous skeletrophin, but not a RING mutant, significantly inhibited colony formation activity of both A2058 and Colo679 cells.
When cells were transplanted into nude mice, A2058skwt remained in subcutaneous tissues, whereas A2058skmut deeply invaded muscle layers ( Figure 5 ).
As C-terminal RING motif is responsible for the ubiquitin ligase activity of skeletrophin (Koo et al., 2005a; Takeuchi et al., 2005) , we concluded that skeletrophin inhibited melanoma cell invasion and soft-agar colony formation activity via a ubiquitin ligase pathway.
Skeletrophin induced Hes1 and reduced c-Met mRNA expression
It is known that c-Met contributes to the invasive phenotype of melanoma cells (Natali et al. 1993 ).
Moreover, Notch activation recently appeared to downregulate Met expression (Stella et al. 2005) . We therefore examined whether skeletrophin could alter c-Met expression. As demonstrated in Figure 6 , c-Met mRNA was less expressed in A2058skwt than in A2058skmut, or A2058 cells.
Western immunoblotting also revealed that skeletrophin markedly reduced expression of active phosphorylated Met receptor ( Figure 6 ). Double immunohistochemical staining revealed that benign nevi cells expressed skeletrophin but not c-met (Figure 7a ). By Silencing of skeletrophin in melanoma T Takeuchi et al contrast, we found c-met expression in at least a part of nine of 28 invasive melanoma cells (Figure 7b) . However, we did not find skeletrophin expression in the nine c-Met-expressing melanoma cells.
Western immunoblotting also demonstrated that cMet and skeletrophin was reciprocally expressed in cell lysates from invasive melanoma specimens tested (Figure 7c ). 
Silencing of skeletrophin in melanoma T Takeuchi et al
Taken together with the results using transfectants, we think that silencing of skeletrophin expression resulted in c-Met expression in invasive melanoma cells.
Finally, we asked whether skeletrophin altered the expression of members of the Notch signaling pathway. A2058 cells expressed Notch1 and Jag1, whereas Colo679 cells expressed Notch1, Delta1 and Jag1. However, no significant difference in gene expression was found for these Notch pathway members and ligands using real-time PCR, as described below. A2058skwt expressed Notch1 mRNA 1.0270.08-and 0.9670.10-fold more than original A2058 and A2058skmut, respectively. A2058skwt expressed Jag1 mRNA 0.9970.11-and 1.0370.06-fold more than original A2058 and A2058skmut, respectively. Colo679skwt expressed Notch1 mRNA 1.0470.08-and 1.0270.04-fold more than original Colo679 and Colo679skmut, respectively. Colo679skwt expressed Delta1 mRNA 0.9670.10-and 1.0470.10-fold more than original Colo679 and Colo679skmut, respectively. Colo679skwt expressed Jag1 mRNA 0.9670.18-and 0.9870.20-fold more than original Colo679 and Colo679skmut, respectively.
In contrast, A2058skwt significantly expressed Hes-1 mRNA 2.970.12 and 5.6670.23 times more than the original A2058 and A2058skmut, respectively (n ¼ 3, Po0.01). Colo679skwt also significantly expressed Hes1 mRNA 2.470.22 and 6.070.14 times more than the original Colo679 and Colo679skmut, respectively (n ¼ 3, Po0.01).
The present data is consistent to previous findings that skeletrophin mediates the ubiquitination of Notch ligands, and subsequently participates in ligand-dependent Notch activation. It is possible that RING-mutated skeletrophin, which entirely lacks ubiquitin ligase activity, dominant negatively downregulated both mind bomb (a paralogue of skeletrophin) and skeletrophin, thus significantly reducing Hes1 expression.
Discussion
As well as being one of the most common karyotypic lesion seen in malignant melanomas, loss of alleles of 1p36 (now recognized as 1p36.31-36.32) was detected at a late event, or vertical phase to metastasis, in melanoma progression (Bale et al., 1989; Goldstein et al., 1993; Dracopoli et al., 1998; Poetsch et al., 2003) . The skeletrophin gene was previously mapped to 1p36.2-3 by fluorescence in situ hybridization analysis (Takeuchi et al., 2003) and later confirmed by the human genome project to be in 1p36.32 and spanning about 14 kb. Therefore, skeletrophin gene is located in the previously reported lesion, where the loss of heterozygosity (LOH) and microsatellite analyses often predicted the presence of tumor suppressor gene that is responsible for tumor invasion and metastasis in cutaneous melanoma.
The present study revealed that aberrant hypermethylation of the skeletrophin promoter was found in six of 31 melanomas. All six cases were in a vertical growth phase or were invasive to the dermis and did not exhibit skeletrophin expression. Interestingly, the identified skeletrophin promoter region contained an E-boxrelated element, 5 0 -CAAGTG-3 0 . Although the typical Sail-binding element, the E-box, is composed of a 5 0 -CAGGTG-3 0 core motif, Snail can also bind to 5 0 -CAAGTG-3 0 . Mauhin et al. (1993) demonstrated that Snail strongly bound to the canonical E-box, whereas it moderately bound the 5 0 -CAAGTG-3 0 element. The present study clearly indicated that Snail repressed the skeletrophin promoter activity via 5 0 -CAAGTG-3 0 element (Figure 3 ). Snail has been characterized as a repressor factor for many tumor suppressor molecules and is overexpressed in many melanoma cells (Poser et al., 2001) .
In addition, we found an AP-2-binding element, 5
0 -GCCNNNGGC-3 0 (5 0 -GCCCTGGGC-3 0 ), in the skeletrophin promoter. AP-2 is a well-characterized transcription factor and is believed to play a tumor-suppressor-like role in melanoma progression by regulating genes involved in invasive melanoma (see review; Tellez and Bar-Eli, 2003) . Interestingly, the present study also revealed that AP-2 expression increased skeletrophin expression in G361 melanoma cells. We think that a combination of hypermethylation, Snail overexpression and AP-2 downregulation might be responsible for skeletrophin silencing in invasive melanoma cells.
Although further extensive examination is needed, including whether a somatic mutation is present in invasive melanoma cells, when combined with previous LOH and microsatellite analyses, it is likely that skeletrophin might be a tumor suppressor factor in melanoma, especially at the late stage, or during invasion into dermis.
How skeletrophin inhibited tumorigenicity of melanoma? Skeletrophin inhibited soft-agar colony formation activity, which indicates anchorage-independent tumor growth, without affecting cell growth on plastic plates in a RING motif-dependent manner. Moreover, wild-type skeletrophin, but not RING mutant, inhibited melanoma cell invasion. As skeletrophin is a RINGmotif-dependent ubiquitin ligase (Koo et al., 2005a; Takeuchi et al., 2005) , abrogation of the skeletrophin ubiquitin ligase pathway may be responsible for tumorigenesis of melanoma. We prepared culture melanoma cell clot tissue sections and immunohistochemically determined the level of expression of skeletrophin as reported previously (Ishihara et al., in press) . Notably, the transfectants exhibited immunoreactivity on staining with the anti-skeletrophin antibody, the same as skeletrophin-positive superficial spreading melanoma cells.
Ubiquitination is sometimes found in the intracellular region of surface membrane proteins and is responsible for internalization of the targeted membrane protein. Skeletrophin, and its paralogue, mind bomb (also reported as DIP-1 (Jin et al., 2002) or mind bomb-1 (Koo et al., 2005b) , target the intracellular region of Notch ligands and mediates ligand-dependent Notch activation. Internalization of Notch ligands followed by ubiquitination by skeletrophin and mind bomb is critical for Notch signal transduction (Itoh et al., 2003; Koo et al., 2005a, b; Pitsouli and Delidakis, 2005; Takeuchi et al., 2005; Wang and Struhl, 2005) . The present study also revealed that skeletrophin-induced Hes1 expression in melanoma cells in a RING motif-dependent manner. We speculate that skeletrophin-mediated Notch signal activation could be tumor suppressive in melanoma cells.
A recent research demonstrated that Hes1 can bind and repress the promoter activity of Met, which product is known as a powerful activator for cancer invasion (Stella et al., 2005) . Notably, the present study also revealed that skeletrophin upregulated Met expression. Taken together, we speculate that skeletrophinmediated Notch signal activation could inhibit melanoma cell invasion by downregulating Met expression.
However, it should be noted that Notch signaling can be both oncogenic and tumor suppressive even in a single-cell type (Radtke and Raj, 2003; Leong and Karsan, 2006) . In fact, one study, which found that the Notch pathway is involved in melanoma progression, presented findings that conflicted with our own (Hoek et al., 2004) . The authors used a microarray assay to demonstrate that gene transcripts for Notch2, encoding a Notch receptor, and its downstream effector, Hey1, were increasingly expressed in advanced melanomas compared with benign nevi and melanocytes. Very recently, Balint et al. (2005) also demonstrated that activation of Notch1 pathway could promote melanoma progression. These data suggested that activation of both Notch1 and 2 receptors could be oncogenic in melanoma cells; however, it should also be noted that Notch1 and 2 can play an opposite role in tumorigenesis in a single tumor cell type (Fan et al., 2004; Parr et al., 2004) . In the present study, we could not find any significant differences in the expression of the Notch receptor and ligand between the skeletrophin-positive and -negative melanoma cells tested.
To elucidate this mystery, further studies are required. It is interesting that skeletrophin reduced c-Met expression in melanoma cells. Stella et al. (2005) also demonstrated that activation of the Notch receptor resulted in transcriptional downregulation of c-Met, suppression of hepatocyte growth factor (HGF)-dependent Ras signaling and impairment of HGF-dependent cellular responses. Notch activation might have an effect on other molecular pathways and sometimes promote oncogenesis and at other times suppresses tumor progression.
Materials and methods
Primer extension analysis
Primer extension analysis with fluorescently labeled oligonucleotide was carried out according to the modified method of Hewett et al. (1998) . Briefly, human placental total RNA and poly(A) þ RNA was purchased from (BD Biosciences Clontech, Palo Alto, CA, USA). Ten mg and 0.5 mg of total RNA and poly(A) þ RNA, respectively, were annealed with an antisense primer, 5 0 -TGAGGAGAGCGGCGGCTGGAAA CTGTG-3 0 , the sequence of which was derived from downstream of the 5 0 -end of the skeletrophin open-reading frame, at 581C for 20 min. Notably, this antisense primer was fluorescently labeled at the 5 0 -end. The primer extension was carried out at 421C for 30 min using 1 U of avian myeloblastosis virusreverse transcriptase (Promega, Madison, WI, USA). The extended product was run and analysed using an automated fluorescent DNA sequencer (ALFexpress, Amersham Biosciences, Piscataway, NJ, USA) on a 6% polyacrylamide denaturing gel. To determine the transcription start site, sequencing of the putative promoter region, describe below, was carried out in parallel. The results were visualized as a Gel View mode.
Skeletrophin gene promoter analyses To examine the promoter region of the skeletrophin gene, a GreatEscApet SEAP system (BD Biosciences Clontech) was employed. For generation of the construct, a sense (5 0 -ATGAGAAACTAGCAGTGCATTGTTCAG-3 0 ) and an antisense (5 0 -TGAGGAGAGCGGCGGCTGGAAACTG TG-3 0 ), identical to the antisense primer used in a primer extension method, were synthesized. The amplified region of the skeletrophin gene was first cloned into pGEM-T vector (Promega) and verified by sequencing. The PCR product was analysed for various motifs using the NCBI web site and the possibility of a CpG island using CpG island searcher. Subsequently, the PCR products were cloned to the pUC18 vector and then subcloned to pSEAP2-Basic plasmid vector (BD Biosciences Clontech). Transfection into COS7 cells was carried out as described previously (Takeuchi et al., 1997) . The promoter activity of the PCR product was measured using a GreatEscApet SEAP fluorescence detection kit (BD Biosciences Clontech) from the supernatant of the cell cultures.
Analysis of methylation status
For the MSP assay, genomic DNA was obtained from paraffin tissue sections that contained both cancerous and noncancerous areas with the Pinpoint Slide DNA Isolation System as described previously (Takeuchi et al., 2002) . Notably, we selected areas in which the tumor dose was at least over 50%. Genomic DNA was modified with sodium bisulfite according to the modified methods of Herman et al. (1996) and Fan et al. (2002) as previously described (Takeuchi et al. 2002) . Briefly, genomic DNA was suspended in 45 ml of 10 mM Tris-HCl (pH 7.4)/0.1 mM ethylenediaminetetraacetic acid with 5 ml 2N NaOH at 371C for 15 min. A 1mg portion of salmon sperm DNA (Sigma-Aldrich Biosciences, St Louis, MO, USA) was added as a carrier before modification. Denatured DNA was modified by treatment with sodium bisulfite (Sigma-Aldrich Biosciences), which converts unmethylated cytosines to uracil but does not change methylated cytosines at 501C for 48 h. The modified DNA was purified using a Wizard DNA purification kit (Promega), treated with NaOH to desulfonate and precipitated with ethanol. The forward and reverse primers for the methylated sequence were 5 0 -CGTTAGTGTTAGC GAGCGCGACGTCGT-3 0 and 5 0 -CAAACACCGAAAATA CGTCACGCGAAAAC-3 0 , whereas those for the unmethylated sequence were 5 0 -GTTGTTAGTGTTAGTGAGTGT GATGTTGT-3 0 and 5 0 -CAAACACCAAAAATACATCAC ACAAACCC -3 0 , respectively. PCR was performed as follows: 951C for 2 min for initial denaturation followed by 35 cycles of 981C for 10 s, 571C (for methylated sequence) or 551C (for unmethylated sequence) for 30 s and 721C for 30 s. Final elongation at 721C for 5 min was also performed. The PCR products were subjected to electrophoresis in 2% agarose gels. The expected product sizes of methylated and unmethylated bands were 122 and 124 bp, respectively. We also carried out PCR with wild-type primers (sense: 5 0 -AGTGCCAGCGAGCGCGACGTCGC-3 0 ; and antisense: 5 0 -CAAGCACCGGAAGTGCGTCACGCG-3 0 ) in order to confirm the step of treatment with sodium bisulfite. The expected product size was 118 bp. In addition, when we did not find wild-type band in unmodified specimens, the further MSP study was not carried out.
Cell culture
Melanoma cell lines, A2058 and G-361 cells, were obtained from Japan Heath Science Research Resourses Bank (Osaka, Japan). Another melanoma cell line, Colo679 cell, and HEK293 cell line were from RIKEN biosource center (Tsukuba, Japan). COS7 cells were maintained in our laboratory. Cells were cultured in Dulbecco's modified Eagle's medium (DMEM) (Gibco Life Technologies, Grand Island, NY, USA) containing 10% heat-inactivated fetal bovine serum (FBS) and 50mg/ml gentamycin (Gibco Life Technologies).
Repression of skeletrophin promoter activity by Snail An entire coding region of human Snail cDNA was generated by RT-PCR by using a LA (long and accurate)-PCR kit (Takara, Ohtsu, Japan) with a sense primer, 5
0 -ATGCC GCGCTCTTTCCTCGTCAGGAAGCCC-3 0 and an antisense primer, 5
0 -TCAGCGGGGACATCCTGAGCAGCCG GACTC-3 0 . Subsequently, cDNA was subcloned into the pTarget-T (Promega) expression vector, which contained a cytomegalovirus promoter element.
Next, a putative E-box-related element, 5 0 -CAAGTG-3 0 , of the skeletrophin promoter region was altered to 5 0 -AAATTT-3 0 by PCR site-directed mutagenesis methods. Briefly, the promoter region of skeletrophin was amplified using the pSEAP2-Basic skeletrophin promoter vector as a template by PCR with a sense primer, 5 0 -CAAACTAGCAAAA TAGGCTGTCCCCAG-3 0 , which annealed the pSEAP2-Basic plasmid at 5 0 -site of inserted skeletrophin promoter and an antisense primer, 5 0 -TTCGACGTCGCGCTCGCTGGCACT GGCGGAAATTTCCGCGC -3 0 , in which the wild E-box, 5 0 -CAAGTG-3 0 , was designed to be altered to 5 0 -AAATTT-3 0 (indicated by the underline). By using the BglII site of pSEAP2-Basic plasmid and an internal AatII site (GACGTC, highlighted in bold in the antisense primer), the E-box-related element containing the skeletrophin promoter region was substituted for that containing the inactive 5 0 -AAATTT-3 0 element. Finally, the identities of all plasmid inserts and vector boundary regions were confirmed by sequence analysis. Transfection into HEK293 cells was carried out as described previously (Takeuchi et al., 1997) . Briefly, HEK293 cells were grown to approximately 60% confluence in six-well plates. 0.8 ı`g wild-type or E-box-mutated skeletrophin-promotercontaining pSEAP2-Basic vectors, and various amounts of Snail-containing-pTarget-T vectors were co-transfected to HEK293 cells using DOTAP reagent (Roche Diagnostic GmbH, Germany) as described previously. The promoter activity was measured using a GreatEscApet SEAP fluorescence detection kit (BD Biosciences Clontech) in the supernatant of the cell cultures.
siRNA-mediated RNA interference The Snail siRNA duplex was obtained from Qiagen Inc. (Valencia, CA, USA). We employed two siRNA duplexes that targeted the sequences as following: Snail (5 0 -GAGGTGT GACTAACTATGCAA-3 0 and 5 0 -AGGACTCTAATCCAGA GTTTA-3 0 ). However, we could not find sufficient downregulation of Snail mRNA using the former duplex in a preliminary assay. Therefore, we performed the assay using the latter Snail siRNA duplex in the present study. We also used GFP siRNA duplex, target sequence (5 0 -CGGCAAGCT GACCCTGAAGTTCAT-3 0 ) as a control. siRNA was transfected into A2058 cells using the Oligofectamine following the manufacturer's instruction (Invitrogen, Carlsbad, CA, USA). At 72 h post-transfection, the cells were harvested.
RT-PCR was performed as described previously (Takeuchi et al. 2003) . The primer sets used in this assay were: sense 5 0 -GCAGCCCCGCCCAACATGGACC-3 0 and antisense, 5 0 -AGCAGTCACAGATGATGTTGGGGTGCC-3 0 for skeletrophin, sense 5 0 -ATG CAC ATC CGA AGC CAC AC-3 0 and antisense, 5 0 -TCA GCG GGG ACA TCC TGA GCA GCC GGA CTC-3 0 for Snail; and sense, 5 0 -TCCACCAC CCTGTTGCTGTA-3 0 and antisense 5 0 -ACCACAGTCCAT GCCATCAC-3 0 for glyceraldehyde-3-phosphate dehydrogenase (G3PDH).
For promoter assay, the A2058 cells were first transfected with the Wt-skprom vector. After 24 h incubation, the cells were treated with siRNAs and were further incubated for 48 h. The promoter activity was measured using a GreatEscApet SEAP fluorescence detection kit (BD Biosciences Clontech) in the supernatant of the cell cultures.
Upregulation of skeletrophin by AP-2 An entire coding region of human AP-2acDNA was generated by RT-PCR using a LA -PCR kit (Takara) with a sense primer, 5 0 -GATCCATGAAAATGCTTTGGAAATTGACG -3 0 and an antisense primer, 5 0 -TCACTTTCTGTGCTTCTCC TCTTTGTCAC -3 0 . Subsequently, cDNA was subcloned into the pTarget-T (Promega) expression vector, verified by sequencing and designated pTarget-AP-2. Preliminary RT-PCR experiments indicated that a melanoma cell, G361, expressed little AP-2 mRNA. The primer sets used for the detection of AP-2 mRNA were: sense, 5 0 -CCCAGCTGGG CACTGTAGGTCAATCTCC -3 0 and antisense, 5 0 -TTAA TACCCGGGTCTTCTACATGCGGGAC-3 0 . G361 cell was transfected with pTarget-AP-2 or empty vector. After G418 selection, three independent AP-2-expressing G361 cells and control cells were established.
Cell invasion assay
The construction and stable transfection of a pCI-neo expression vector (Promega) containing a human wild-type skeletrophin and a C-terminal RING mutant, C969S, were reported previously (Takeuchi et al. 2005) . Notably, the Cterminal RING mutant of skeletrophin entirely lost ubiquitin ligase activity.
Cell proliferation was evaluated by measuring live cells as described previously. Melanoma cells (2X10 4 ) were cultured on standard 60 mm tissue culture dishes (BD Biosciences) in triplicate. After 24, 48 and 72 h, live cells were counted.
The invasion activities of cultured melanoma cells were determined with BD BioCoat Matrigel Invasion Chamber (BD Biosciences) according to the manufacturer's protocol. Briefly, 1 Â 10 3 melanoma cells were placed in the upper compartment of an invasion chamber. After 22 h of incubation with DMEM containing 10% (lower chamber) and 1% (upper chamber) FCS, the cells on the lower surface of the filter were counted. The experiments were performed in triplicate well. The mean and standard deviation were calculated from four dependent assays.
The invasion activity was also evaluated by two independent xenografting in nude mice. In each assay, a total of 1 Â 10 6 A2058skmut or A2058skwt cells were subcutaneously injected into five nude mice. Tissue specimens of transplanted tumor
Silencing of skeletrophin in melanoma T Takeuchi et al were prepared on day 30. Immunohistochemical staining was performed as described previously.
Colony formation assay in soft agar Colony formation was evaluated using the soft-agar plate assay. Briefly, 3 Â 10 4 cultured melanoma cells per well were embedded into 0.33% agar gel containing DMEM and FBS in six-well plates, which were precoated with 0.5% agar solution in DMEM--10% FCS, and subsequently covered with DMED containing 10% FCS. After 10 days of culture, colonies (defined as a minimum of 10 cells) were counted. The assay was performed in triplicate wells and repeated twice.
Expression status of Met in skeletrophin-expressing melanoma cells Semi-quantitative RT-PCR was performed as described previously (Takeuchi et al. 2005) . Briefly, total cellular RNA was prepared from cell lysates using RNA-zol B (Biotex Laboratory, Houston, TX, USA). Serial dilutions were prepared from master lysates and used as a set in RT-PCR. cDNA synthesis from total RNA and subsequent PCR were performed using an RNA-LA -PCR kit (Takara). The primer sets used in this assay were: sense, 5 0 -TGGGAATCTGCCT GCGAA-3 0 and antisense, 5 0 -CCAGAGGACGACGCCAAA-3 0 for c-met; and sense, 5 0 -TCCACCACCCTGTTGCTGTA-3 0 and antisense, 5 0 -ACCACAGTCCATGCCATCAC-3 0 for G3PDH. The PCR-amplified products were separated by electrophoresis on a 2% agarose gel. In order to assure reproducibility of results, the RT-PCR amplification was repeated at three times using different clones.
The activation status of c-Met was evaluated by measuring the level of phosphorylation using Western immunoblotting as described before (Takeuchi et al., 2000) . We used a conventional antibody to c-Met (C-12) (Santa Cruz Biotechnology, Santa Cruz, CA, USA) and a phosphorylation (tyrosine 1230/ 1234/1235)-specific antibody (Biosource International Camarillo, CA, USA). To monitor the applied protein volume, we used anti-major histocompatibility complex (MHC) class antibody (H-300, Santa Cruz Biotechnology, Santa Cruz, CA, USA).
We also performed double immunohistochemical staining with anti-skeletrophin antibody and c-Met antibody (Santa Cruz Biotechnology, Santa Cruz, CA, USA) using a commercially available kit (Histo-DS kit, Zymed Laboratories Inc., San Francisco, CA, USA). The detailed procedure for generating specific antibody to skeletrophin was described before (Takeuchi et al., 2003) .
Evaluation of Notch receptors, ligands and Hes1 expression
In order to examine the expression status of members of the Notch pathway, RT-PCR was first performed according to the methods of Zweidler-McKay et al. (2005) and Nijjar et al. (2002) . The primers set used in this assay are shown in Table 1 . Because we found Notch1, 2, Jag1, Delta1 and Hes1 expression in melanoma cells, we further examined the RNA level by quantitative PCR with TaqMan probes (Applied Biosystem's (ABI) Prism 7000, Foster City, CA, USA). In order to assure reproducibility of results, the quantitative PCR amplification was performed using different clones and repeated at least three times for each clone.
Primer/probes: Set -Hs 00413187-ml (Notch1), Hs 00225747-ml (Notch2), Hs 00164982-ml (Jag1), Hs 00172878-ml (Hes1), Hs 00194509-ml (Delta), Hs 00195591-ml (Snail) and Hs 99999905-ml (G3PDH) were purchased from ABI. Silencing of skeletrophin in melanoma T Takeuchi et al
